These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 18471475

  • 21. First-line therapies for lowering triglyceride levels.
    Raghavan VA.
    Am Fam Physician; 2008 Feb 15; 77(4):416; author reply 417-8. PubMed ID: 18326158
    [No Abstract] [Full Text] [Related]

  • 22. [Therapy of dyslipidemia in post-infarction: state of the art].
    Borgia MC, Nardi M, Da Ros S, Castellano V.
    Clin Ter; 2007 Feb 15; 158(6):523-32. PubMed ID: 18265719
    [Abstract] [Full Text] [Related]

  • 23. Fibrates: where are we now?
    Seth Loomba R, Arora R.
    Ther Adv Cardiovasc Dis; 2009 Feb 15; 3(1):91-6. PubMed ID: 19144670
    [Abstract] [Full Text] [Related]

  • 24. Treatment of the dyslipidemia of insulin resistance.
    Smith DA.
    Med Clin North Am; 2007 Nov 15; 91(6):1185-210, x. PubMed ID: 17964916
    [Abstract] [Full Text] [Related]

  • 25. Expert commentary: the safety of fibrates in lipid-lowering therapy.
    Brown WV.
    Am J Cardiol; 2007 Mar 19; 99(6A):19C-21C. PubMed ID: 17368273
    [Abstract] [Full Text] [Related]

  • 26. Fibrates plus betaine: a winning combination?
    Lever M, George PM, Slow S, Elmslie JL, Shand BI, Scott RS, Chambers ST.
    N Z Med J; 2010 Oct 15; 123(1324):74-8. PubMed ID: 20953225
    [Abstract] [Full Text] [Related]

  • 27. Dyslipidaemia in diabetes.
    Patel J.
    Clin Evid; 2006 Jun 15; (15):555-75. PubMed ID: 16973026
    [No Abstract] [Full Text] [Related]

  • 28. A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndrome.
    Davidson M.
    Am J Cardiol; 2008 Dec 22; 102(12A):19L-27L. PubMed ID: 19084086
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Drugs for lipids.
    Treat Guidel Med Lett; 2005 Mar 22; 3(31):15-22. PubMed ID: 15726011
    [No Abstract] [Full Text] [Related]

  • 32. Safety considerations with fibrate therapy.
    Davidson MH, Armani A, McKenney JM, Jacobson TA.
    Am J Cardiol; 2007 Mar 19; 99(6A):3C-18C. PubMed ID: 17368275
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. When a statin fails.
    Med Lett Drugs Ther; 2009 Jul 27; 51(1317):58-60. PubMed ID: 19636290
    [No Abstract] [Full Text] [Related]

  • 36. Clinical practice. Hypertriglyceridemia.
    Brunzell JD.
    N Engl J Med; 2007 Sep 06; 357(10):1009-17. PubMed ID: 17804845
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Fenofibric Acid (trilipix).
    Med Lett Drugs Ther; 2009 May 04; 51(1311):33-4. PubMed ID: 19417718
    [No Abstract] [Full Text] [Related]

  • 39. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease.
    Staels B, Maes M, Zambon A.
    Nat Clin Pract Cardiovasc Med; 2008 Sep 04; 5(9):542-53. PubMed ID: 18628776
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.